Jun 19, 2009
By:
Chitra Sethi
Vetter Pharma International (Ravensburg, Germany) has completed the installation of six automatic packaging lines at Vetter Secondary Packaging (VSP), the company?s new packaging services facility.
|
Jun 17, 2009
By:
Chitra Sethi
The newly formed Rx-360 consortium had an impressive turnout of over 125 people at its launch meeting in Washington, DC, on June 5.
|
Jun 16, 2009
By:
Chitra Sethi
A new report by FTC, entitled ?Follow-on Biologic Drug Competition,? examines whether the price of biologics is likely to be reduced by competition from FOBs.
|
Apr 9, 2009
By:
Chitra Sethi
ImClone Systems, Inc. (Branchburg, NJ), and Bristol-Myers Squibb (BMS, New York, NY) voluntarily recalled 13 lots of their cancer drug Erbitux (cetuximab) after a report from a doctor?s office about a leaking cap on a vial of the biologic.
|
BioPharm International's third annual salary survey finds out if the turbulent economic climate is taking its toll on the biopharmaceutical sector.
Jan 1, 2009
By:
Chitra Sethi
Will the global economic crisis affect your job? BioPharm International's third annual salary survey finds out.
|
Oct 3, 2008
By:
Chitra Sethi
Eli Lilly (Indianapolis, In) is the mystery bidder "in advanced talks" to acquire ImClone Systems (New York, NY).
|
Sep 10, 2008
By:
Chitra Sethi
Biotechnology company ImClone Systems (New York, NY) has rejected the offer it received last month from its cancer drug partner Bristol-Myers (BMS, New York, NY) to acquire ImClone for $60 per share.
|
Aug 4, 2008
By:
Chitra Sethi
Bristol-Myers Squibb has proposed to acquire its cancer drug partner ImClone Systems in an all-cash deal worth around $4.5 billion.
|
|
